Status:

UNKNOWN

Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker

Lead Sponsor:

Corporacion Parc Tauli

Conditions:

Acute Diverticulitis

Eligibility:

All Genders

18-90 years

Brief Summary

The management of acute diverticulitis maybe better if we have prognostic markers of evolution. Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis. Th...

Detailed Description

A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test. The investigators will predict evolution o...

Eligibility Criteria

Inclusion

  • Acute Diverticulitis

Exclusion

  • Other Abdominal Pathologies

Key Trial Info

Start Date :

April 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2014

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01825967

Start Date

April 1 2013

End Date

April 1 2014

Last Update

April 10 2013

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Corporacion Parc Tauli

Sabadell, Barcelona, Spain, 08208

2

Corporacion parc tauli

Sabadell, Sabadell-Barcelona, Spain, 08208

3

Corporacion Parc Tauli

Sabadell, Sabadell/barcelona, Spain, 08208

4

Corporacion Parc Tauli

Sabadell, Sabadell/barcelona, Spain, 08208

Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker | DecenTrialz